A detailed history of Burkett Financial Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Burkett Financial Services, LLC holds 216 shares of ABBV stock, worth $38,532. This represents 0.02% of its overall portfolio holdings.

Number of Shares
216
Previous 134 61.19%
Holding current value
$38,532
Previous $23 Million 85.33%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$163.84 - $199.33 $13,434 - $16,345
82 Added 61.19%
216 $42.6 Million
Q2 2024

Jul 10, 2024

BUY
$154.79 - $180.76 $154 - $180
1 Added 0.75%
134 $23 Million
Q1 2024

Apr 01, 2024

BUY
$159.82 - $182.1 $159 - $182
1 Added 0.76%
133 $24.2 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $18,163 - $20,456
132 New
132 $20.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Burkett Financial Services, LLC Portfolio

Follow Burkett Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burkett Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burkett Financial Services, LLC with notifications on news.